Drug Trial Radar · NCT04024137
Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A
Last checked: Nov 19, 2026Latest source record: Jun 4, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
172
Actual
Start
Dec 7, 2019
Primary completion
May 18, 2020
Study completion May 18, 2020
Sponsor
- Lead sponsor
- Guangdong Raynovent Biotech Co., LtdIndustry
- Sponsor type
- Industry
- First posted
- Jul 18, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the antiviral effect, as measured by the time to alleviation of influenza symptoms and viral titer in nasopharyngeal secretions in adults with acute uncomplicated influenza A following administration of ZSP1273.
Conditions
- Influenza A
Interventions
ZSP1273 200 mgDrug
1 X 200-mg tablet taken orally
PlaceboDrug
2 tablets taken orally
ZSP1273-400 mgDrug
2 X 200-mg tablet taken orally
PlaceboDrug
1 tablet taken orally
ZSP1273-600 mgDrug
3 X 200-mg tablet taken orally
PlaceboDrug
3 tablets taken orally
PlaceboDrug
Subjects will receive matching placebo of ZSP1273
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to alleviation of influenza symptoms in participantsTime frame: Initiation of study treatment (Day 1) up to Day 15
Locations
26 sites in 1 country. Site status is shown where the registry gives one.
The Second Hospital Of Anhui Medical University
Hefei, Anhui, China
Beijing Ditan Hospital Capital Medical University
Beijing, Beijing Municipality, China
Beijing Luhe Hospital,Capital Medical University
Beijing, Beijing Municipality, China
Peking University Third Hospital
Beijing, Beijing Municipality, China
Zhongshan Hospital Xiamen University
Xiamen, Fujian, China
Dongguan people's Hospital
Dongguan, Guangdong, China
Nanfang Hospital,South Medical Hospital
Guangzhou, Guangdong, China
The First Affiliated Hospital Of Guangzhou Medical University
Guangzhou, Guangdong, China
Traditional Chinese Medicine Hospital of Guangdong Province
Guangzhou, Guangdong, China
Huizhou Municipal Central Hospital
Huizhou, Guangdong, China
Jieyang People's Hospital
Jieyang, Guangdong, China
Shenzhen People's Hospital
Shenzhen, Guangdong, China
Affiliated Hospital Of Guangdong Medical University
Zhanjiang, Guangdong, China
Henan Provincial People's Hospital
Zhengzhou, Henan, China
The Sixth People's Hospital Of Zhengzhou
Zhengzhou, Henan, China
Sir Run Run Hospital Nanjing Medical University
Nanjing, Jiangsu, China
Jiujiang University Hospital
Jiujiang, Jiangxi, China
The First Affiliated Hospital Of Nanchang University
Nanchang, Jiangxi, China
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China
Linyi People's Hospital
Linyi, Shandong, China
Qingdao Municipal Hospital
Qingdao, Shandong, China
First Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
Chengdu Fifth People's Hospital
Chengdu, Sichuan, China
General Hospital, Tianjin Medical University
Tianjin, Tianjin Municipality, China
The First Affiliated Hospital,Zhejiang University
Hangzhou, Zhejiang, China
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.